Imatinib mesylate causes growth plate closure in vivo.
Vandyke
K
K
Dewar
A L
AL
Fitter
S
S
Menicanin
D
D
To
L B
LB
Hughes
T P
TP
Zannettino
A C W
AC
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000494:pharmacology; D001549:Benzamides; D002648:Child; D005260:Female; D006130:Growth Disorders / Q000139:chemically induced*; D006132:Growth Plate / Q000187:drug effects*; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D010879:Piperazines / Q000009:adverse effects* / Q000494:pharmacology; D011743:Pyrimidines / Q000009:adverse effects* / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate